117 related articles for article (PubMed ID: 6096462)
21. Virilizing Brenner tumor of the ovary: case report.
de Lima GR; de Lima OA; Baracat EC; Vasserman J; Burnier M
Obstet Gynecol; 1989 May; 73(5 Pt 2):895-8. PubMed ID: 2649834
[TBL] [Abstract][Full Text] [Related]
22. In vivo endocrine studies in adrenal rest tumor of ovary.
Parker CR; Servy E; McDonough PG; Mahesh VB
Obstet Gynecol; 1974 Sep; 44(3):327-32. PubMed ID: 4277531
[No Abstract] [Full Text] [Related]
23. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
24. Steroid biosynthesis in the Sertoli-Leydig cell tumor: effects of insulin and luteinizing hormone.
Nagamani M; Stuart CA; Van Dinh T
Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1738-43. PubMed ID: 2532472
[TBL] [Abstract][Full Text] [Related]
25. Virilizing serous cystadenoma.
Beauchamp PJ; Hughes RS; Schmidt WA
Obstet Gynecol; 1989 Mar; 73(3 Pt 2):513-7. PubMed ID: 2915883
[TBL] [Abstract][Full Text] [Related]
26. Sertoli-Leydig cell tumour of the ovary--a rare cause of virilization after menopause.
Hansen TP; Sørensen B
APMIS; 1993 Sep; 101(9):663-6. PubMed ID: 8240784
[TBL] [Abstract][Full Text] [Related]
27. Cystogenesis of the ovarian antral follicle of the rat: ultrastructural changes and hormonal profile following the administration of dehydroepiandrosterone.
Anderson E; Lee MT; Lee GY
Anat Rec; 1992 Nov; 234(3):359-82. PubMed ID: 1443664
[TBL] [Abstract][Full Text] [Related]
28. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
29. In vitro production of cyclic AMP and steroids from an ovarian Sertoli-Leydig cell tumor. Notes on clinical management.
Abrahamsson G; Dahlgren E; Hahlin M; Knutson F; Norström A; Janson PO
Acta Obstet Gynecol Scand; 1995 Apr; 74(4):310-7. PubMed ID: 7732806
[TBL] [Abstract][Full Text] [Related]
30. Sertoli-Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism.
Turra J; Granzotto M; Gallea M; Faggian D; Conte L; Litta P; Vettor R; Mioni R
Gynecol Endocrinol; 2015 Jan; 31(1):18-21. PubMed ID: 25299229
[TBL] [Abstract][Full Text] [Related]
31. 17 beta-hydroxysteroid dehydrogenase deficiency in malignant interstitial cell carcinoma of the testis.
Davis S; DiMartino NA; Schneider G
J Clin Endocrinol Metab; 1980 Dec; 51(6):1293-7. PubMed ID: 6449517
[TBL] [Abstract][Full Text] [Related]
32. [Endocrinological study of Sertoli-Leydig cell tumor].
Haruyama Y; Miyakawa I; Inoue H; Mori N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):765-70. PubMed ID: 2955060
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.
Regnier C; Bennet A; Malet D; Guez T; Plantavid M; Rochaix P; Monrozies X; Louvet JP; Caron P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3074-7. PubMed ID: 12107203
[TBL] [Abstract][Full Text] [Related]
34. [Histogenesis on the ovarian Leydig cell tumor--light microscopic dry-mounting radioautography for 3H-cholesterol and electron microscopic cytochemistry for 3 beta-hydroxysteroid dehydrogenase activity].
Muta M; Yorishima M; Nagai N; Nogawa T; Hiura M; Fujiwara A
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):661-4. PubMed ID: 6575107
[TBL] [Abstract][Full Text] [Related]
35. Sertoli-Leydig cell tumor.
Lantzsch T; Stoerer S; Lawrenz K; Buchmann J; Strauss HG; Koelbl H
Arch Gynecol Obstet; 2001 Jan; 264(4):206-8. PubMed ID: 11205710
[TBL] [Abstract][Full Text] [Related]
36. Bilateral microscopic Leydig cell ovarian tumors in the postmenopausal woman.
Langevin TL; Maynard K; Dewan A
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370966
[TBL] [Abstract][Full Text] [Related]
37. [Endocrine studies of juvenile amenorrhea associated with ovarian androblastoma].
Himeno R; Kinoshita K; Matsuyama S; Munemura M; Maeyama M
Horumon To Rinsho; 1983 Dec; 31(12):1197-202. PubMed ID: 6323061
[No Abstract] [Full Text] [Related]
38. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
Klotz RK; Müller-Holzner E; Fessler S; Reimer DU; Zervomanolakis I; Seeber B; Mattle V; Wildt L
Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
[TBL] [Abstract][Full Text] [Related]
39. [Androblastoma in a female patient with the signs of virility: a clinical-morphological and genetic study].
Warenik-Szymankiewicz A; Słopień R; Kedzia H; Kusz K
Ginekol Pol; 1999 May; 70(5):305-10. PubMed ID: 10462971
[TBL] [Abstract][Full Text] [Related]
40. Elevated secretion of androstenedione in a patient with a Leydig cell tumour.
Boulanger P; Somma M; Chevalier S; Bleau G; Roberts KD; Chapdelaine A
Acta Endocrinol (Copenh); 1984 Sep; 107(1):104-9. PubMed ID: 6435367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
